[Antibacterial activities of lincomycin and clindamycin against anerobic bacteria].
D000693:Anaerobiosis; D001439:Bacteroides / Q000187:drug effects; D002981:Clindamycin / Q000494:pharmacology; D003016:Clostridium perfringens / Q000187:drug effects; D003017:Clostridium tetani / Q000187:drug effects; D004917:Erythromycin / Q000494:pharmacology; D005673:Fusobacterium / Q000187:drug effects; D007933:Leucomycins / Q000494:pharmacology; D008034:Lincomycin / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D010460:Peptococcus / Q000187:drug effects; D010462:Peptostreptococcus / Q000187:drug effects; D014678:Veillonella / Q000187:drug effects
D007933:Leucomycins; D002981:Clindamycin; D004917:Erythromycin; D008034:Lincomycin